1)Asano T, Tanaka K, Yamakawa N, et al. HSP70 confers protection against indomethacin-induced lesions of the small intestine. J Pharmacol Exp Ther. 2009; 330: 458-67
|
|
|
2)Suemasu S, Tanaka K, Namba T, et al. A role for HSP70 in protecting against indomethacin-induced gastric lesions. J Biol Chem. 2009; 284: 19705-15
|
|
|
3)Tanaka K, Namba T, Arai Y, et al. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem. 2007; 282: 23240-52
|
|
|
4)Matsuda M, Hoshino T, Yamashita Y, et al. Prevention of UVB radiation-induced epidermal damage by expression of heat shock protein 70. J Biol Chem. 2010; 285: 5848-58
|
|
|
5)Hoshino T, Murao N, Namba T, et al. Suppression of Alzheimer’s disease-related phenotypes by expression of heat shock protein 70 in mice. J Neurosci. 2011; 31: 5225-34
|
|
|
6)Hoshino T, Matsuda M, Yamashita Y, et al. Suppression of melanin production by expression of HSP70. J Biol Chem. 2010; 285: 13254-63
|
|
|
7)Tanaka K, Tanaka Y, Namba T, et al. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice. Biochem Pharmacol. 2010; 80: 920-31
|
|
|
8)Namba T, Tanaka K, Hoshino T, et al. Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis. PLoS One. 2011; 6: e27296
|
|
|
9)Tanaka K, Ishihara T, Azuma A, et al. Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010; 298: L348-60
|
|
|
10)Tanaka K, Sato K, Aoshiba K, et al. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis. Chest. 2012 in press
|
|
|